Polymorphism of benzylthiouracil, an active pharmaceutical ingredient against hyperthyroidism.
Sign Up to like & getrecommendations! Published in 2021 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2021.120378
Abstract: The crystal structures of dimorphic benzylthiouracil, a drug against hyperthyroidism, have been redetermined and the atom coordinates of the two independent molecules of form I have been obtained for the first time. The dimorphism convincingly… read more here.
Keywords: hyperthyroidism; ingredient hyperthyroidism; benzylthiouracil active; active pharmaceutical ... See more keywords